Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset

被引:4
作者
Leiva-Salinas, C. [1 ,2 ]
Aghaebrahim, A. [3 ]
Zhu, G. [1 ,4 ]
Patrie, J. T. [5 ]
Xin, W. [5 ]
Lau, B. C. [1 ]
Jovin, T. [3 ]
Wintermark, M. [1 ]
机构
[1] Univ Virginia, Dept Radiol, Neuroradiol Div, Charlottesville, VA 22908 USA
[2] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
[3] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[4] Mil Gen Hosp Beijing PLA, Dept Neurol, Beijing, Peoples R China
[5] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA
关键词
Stroke; CT; MRI; Thrombolytics; Infarction; ACUTE ISCHEMIC-STROKE; HYPOXIC TISSUE; TIME; THROMBOLYSIS; ALTEPLASE; OCCLUSION; F-18-FLUOROMISONIDAZOLE; RECANALIZATION; DESMOTEPLASE; DIFFUSION;
D O I
10.1007/s00234-013-1164-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The decision on thrombolytics administration is usually based on a generalized, rigid time-based rule rather than an individualized evaluation of the "tissue at risk of infarction" which is the target of the recanalization therapies. The goals of our article are to assess whether there is tissue at risk of infarction in a group of acute stroke patients treated beyond 8 h after symptom onset and to investigate the baseline imaging and clinical features that predict the fate of this tissue at risk. We retrospectively reviewed a series of patients with acute ischemic stroke treated with endovascular recanalization therapies beyond 8 h after symptom onset. The tissue at risk was calculated as the difference between the infarct volumes on baseline and follow-up imaging (infarct growth). We analyzed the epidemiological distribution of infarct growth, and we performed a multivariate regression analysis to identify the baseline variables that predict infarct growth. Our study group included 75 patients (65 +/- 13.8 years, baseline National Institutes of Health Stroke Scale 14 +/- 4.9, time to treatment 15.2 +/- 8.7 h). The mean infarct growth was 78.6 +/- 95.0 cc (p < 0.001), and, overall, the infarct growth was greater when the baseline volume of infarct tissue was small (p < 0.001) and in the case of a unsuccessful arterial recanalization (p = 0.001). There is potentially salvageable ischemic tissue at risk in acute stroke patients treated beyond 8 h after symptom onset.
引用
收藏
页码:807 / 812
页数:6
相关论文
共 22 条
[1]   Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients [J].
Abou-Chebl, Alex .
STROKE, 2010, 41 (09) :1996-2000
[2]   Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study [J].
Albers, Gregory W. ;
Thijs, Vincent N. ;
Wechsle, Lawrence ;
Kemp, Stephanie ;
Schlaug, Gottfried ;
Skalabrin, Elaine ;
Bammer, Roland ;
Kakuda, Wataru ;
Lansberg, Maarten G. ;
Shuaib, Ashfaq ;
Coplin, William ;
Hamilton, Scott ;
Moseley, Michael ;
Marks, Michael P. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :508-517
[3]   Reasons why few patients with acute stroke receive tissue plasminogen activator [J].
Bambauer, Kara Z. ;
Johnston, S. Claiborne ;
Bambauer, Derek E. ;
Zivin, Justin A. .
ARCHIVES OF NEUROLOGY, 2006, 63 (05) :661-664
[4]   Existence of the Diffusion-Perfusion Mismatch within 24 Hours after Onset of Acute Stroke: Dependence on Proximal Arterial Occlusion [J].
Copen, William A. ;
Gharai, Leila Rezai ;
Barak, Elizabeth R. ;
Schwamm, Lee H. ;
Wu, Ona ;
Kamalian, Shahmir ;
Gonzalez, R. Gilberto ;
Schaefer, Pamela W. .
RADIOLOGY, 2009, 250 (03) :878-886
[5]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[6]   Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset [J].
Furlan, AJ ;
Eyding, D ;
Albers, GW ;
Al-Rawi, Y ;
Lees, KR ;
Rowley, HA ;
Sachara, C ;
Soehngen, M ;
Warach, S ;
Hacke, W .
STROKE, 2006, 37 (05) :1227-1231
[7]   The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].
Hacke, W ;
Albers, G ;
Al-Rawi, Y ;
Bogousslavsky, J ;
Davalos, A ;
Eliasziw, M ;
Fischer, M ;
Furlan, A ;
Kaste, M ;
Lees, KR ;
Soehngen, M ;
Warach, S .
STROKE, 2005, 36 (01) :66-73
[8]   Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].
Hacke, Werner ;
Kaste, Markku ;
Bluhmki, Erich ;
Brozman, Miroslav ;
Davalos, Antoni ;
Guidetti, Donata ;
Larrue, Vincent ;
Lees, Kennedy R. ;
Medeghri, Zakaria ;
Machnig, Thomas ;
Schneider, Dietmar ;
von Kummer, Ruediger ;
Wahlgren, Nils ;
Toni, Danilo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329
[9]   The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion [J].
Jovin, TG ;
Yonas, H ;
Gebel, JM ;
Kanal, E ;
Chang, YF ;
Grahovac, SZ ;
Goldstein, S ;
Wechsler, LR .
STROKE, 2003, 34 (10) :2426-2433
[10]   Imaging-Based Endovascular Therapy for Acute Ischemic Stroke due to Proximal Intracranial Anterior Circulation Occlusion Treated Beyond 8 Hours From Time Last Seen Well Retrospective Multicenter Analysis of 237 Consecutive Patients [J].
Jovin, Tudor G. ;
Liebeskind, David S. ;
Gupta, Rishi ;
Rymer, Marilyn ;
Rai, Ansaar ;
Zaidat, Osama O. ;
Abou-Chebl, Alex ;
Baxter, Blaise ;
Levy, Elad I. ;
Barreto, Andrew ;
Nogueira, Raul G. .
STROKE, 2011, 42 (08) :2206-U294